Patients (n)** | Stable X4 (22) | Stable R5 (51) | Switch to X4 (6) | Switch to R5 (7) |
---|---|---|---|---|
CD4 T1a cells/mm3 | 431 (130 – 950) | 560 (54 – 1170) | 600 (330 – 860) | 420 (315 – 890) |
CD4 T2a cells/mm3 | 520 (170 – 1110) | 615 (92 – 1291) | 540 (290 – 970) | 535 (420 – 740) |
HIV DNA T1a Copies/106PBMCs | 41 (<5 – 657) | 95 (<5 – 892) | 75.5 (<5 – 532) | 196 (18 – 424) |
HIV DNA T2a Copies/106PBMCs | 50.5 (<5 – 448) | 83 (<5 – 469) | 31 (<5 – 412) | 70 (7 – 147) |
HIV RNA <2,5 copies/ml (n/total n patients and percentage)b | 2/22 (9.1%) | 19/51 (37.2%) | 4/6 (66.7%) | 1/7 (14.3%) |